Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [<sup>177</sup>Lu]Lu-DOTATATE Treatment.

Hemmingsson, Jens; Svensson, Johanna; Hallqvist, Andreas; Smits, Katja; Johanson, Viktor; Bernhardt, Peter

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [¹⁷⁷Lu]Lu-DOTATATE Treatment.

Hemmingsson, Jens; Svensson, Johanna; Hallqvist, Andreas; Smits, Katja; Johanson, Viktor; Bernhardt, Peter.

Affiliation

Hemmingsson J; Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden; jens.hemmingsson@gu.se.
Svensson J; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
Hallqvist A; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Smits K; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
Johanson V; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Bernhardt P; Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.

J Nucl Med ; 64(9): 1456-1462, 2023 09.

Article de En | MEDLINE | ID: mdl-37290797

Sujet(s)
Mots clés

177Lu; DOTATATE; SPECT; dosimetry; red marrow

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Composés organométalliques / Tumeurs osseuses / Tumeurs neuroendocrines Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: J Nucl Med Année: 2023 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google